A recent work confirmed that anti-integrin αvβ6 IgG performed better than calprotectin and C-reactive protein (CRP) in distinguishing UC from diseased controls (including IBS, celiac disease, and other conditions). This evidence concerns the gene CRP and irritable bowel syndrome.